Skip to content
Home/ Galectins and Disease Implications for Targeted Therapeutics
Galectins and Disease Implications for Targeted Therapeutics

Galectins and Disease Implications for Targeted Therapeutics

No customer reviews yet ISBN 9781639897759

Galectins are a class of carbohydrate-binding proteins characterized by the presence of b-galactoside-binding sites. They are also referred to as S-type lectins. These molecules are involved in many physiological and biological functions of the body such as inflammation, immune responses, cell migration, autophagy, RNA splicing, gene transcription, apoptosis, signaling and differentiation. Galectins have also been linked to diseases such as fibrosis, cancer and heart disease. Galectin-3 plays a considerable role in cancer progression and the processes associated with tumorigenesis such as transformation to a malignant form, metastasis, and increased invasive properties of tumor cells. It has also been researched as a potential biomarker of rheumatic diseases. Galectins have a unique mechanism to intracellularly as well as extracellularly regulate cell death. This book is compiled in such a manner, that it will provide in-depth knowledge about the role of galectins in disease. It includes contributions of experts and scientists, which will provide innovative insights into this area of study. The extensive content of this book provides the readers with a thorough understanding of the subject.

About the author

Product details

Pub dateSep 26, 2023
ISBN-101639897755
ISBN-139781639897759
LanguageEnglish
Last updated 2026-08-04 09:49
$123.20 $152.00 18% off
You save $28.80 · list price $152.00
In stock — ships in 24 hours with free tracking
Delivery by Wednesday, October 7, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Genetics
See all
Polymers and Nanomaterials for Gene Therapy
<p><i>Polymers and Nanomaterials for Gene Therapy</i> provides the latest information on gene therapy, a topic that has attracted significant attention over the past two decades for the treatment of inherited and acquired genetic diseases. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy.</p> <p>The book explores the most recent developments in the field of polymer science and nanotechnology, and how these advancements have helped in the design of advanced materials. Non-viral vector systems, including cationic lipids, polymers, dendrimers, peptides and nanoparticles, are potential routes for compacting DNA for systemic delivery. However, unlike viral analogues that have no difficulty in overcoming cellular barriers and immune defense mechanisms, non-viral gene carriers consistently exhibit significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Therefore, biocompatibility and potential for large-scale production make these compounds increasingly attractive for gene therapy.</p> <p>This book contains chapters on the engineering of polymers and nanomaterials for gene therapy, and how they can form complexes with DNA and avoid both in vitro and in vivo barriers. Other chapters describe in vitro, ex vivo, in vivo gene therapy studies, and the current issues affecting non-viral gene therapy.</p>
$242.85